Insmed (INSM) Amortization - Intangibles (2018 - 2026)
Insmed (INSM) posted quarterly Amortization - Intangibles of $2.1 million for Q1 2026, up 64.77% year-over-year from $1.3 million in Q1 2025, and up 7.43% quarter-over-quarter from $1.9 million in Q4 2025.
Insmed (INSM) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Insmed's Amortization - Intangibles history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 64.77% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $6.8 million (up 34.98% YoY), while the FY2025 annual figure was $6.0 million, up 18.78% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $2.1 million, up from $1.9 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $2.1 million in Q1 2026, with the low at $1.3 million in Q1 2022.
- The 5-year median for Amortization - Intangibles is $1.3 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2026: Amortization - Intangibles retreated 0.08% in 2022, then soared 64.77% in 2026.
- Insmed's Amortization - Intangibles stood at $1.3 million in 2022, then slipped by 0.08% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024, then soared by 53.37% to $1.9 million in 2025, then climbed by 7.43% to $2.1 million in 2026.
- Business Quant data shows INSM's Amortization - Intangibles at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 1.26 Mn |
| Mar 31, 2022 | 1.26 Mn |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.26 Mn |